Psychopharmacologyinstitute.com Website Review

UNBIASED AND PRACTICAL PSYCHOPHARMACOLOGY UPDATES FOR PRESCRIBERS. This presentation summarizes the benefits of obtaining antipsychotic plasma levels in nonresponding patients. In this episode, we review principles of prescribing psychotropics in patients with liver, kidney and lung diseases with Dr. James Levenson. PSYCHOTROPICS AND GASTROINTESTINAL CONDITIONS: PRESCRIBE WITH THE GUT IN MIND. In this episode, we learn to prescribe with the gut in mind. Dr. James Levenson (Virginia Commonwealth University) joins us with to-the-point tips on prescribing psychotropics in patients with GI disease as well as exploring how psychotropics can affect the GIT. In this episode, we uncover clinical pearls of geriatric psychopharmacology. We are joined by Dr. Sandra Jacobson of the University of Arizona giving practical tips on prescribing for this special group of patients. In this podcast episode, we take on the challenge of treatment-resistant depression and its thera*eutic options. Dr. Philip Cowen (University of Oxford) provided insights for this clinical conundrum with a simple algorithm. MDMA (3,4-methylenedioxymethamphetamine) is being studied for treatment-resistant PTSD. This presentation discusses results from In this episode, we venture into the psychopharmacology of agitation, with a special focus on psychotic agitation. Dr. Michael Jibson (University of Michigan) and Dr. David Osser (Harvard Medical School) shared clinical pearls to treat this challenging situation. cognition. It also discusses findings from neuroimaging studies involving 5-HT1A and 5-HT2A receptors. This presentation discusses how to address partial response to pharmacotherapy in the treatment of GAD. When to switch and when to When is the right time to discontinue an antipsychotic in the treatment of schizophrenia? We reviewed the evidence as well as